| First Author | Ma X | Year | 2019 |
| Journal | Aging (Albany NY) | Volume | 11 |
| Issue | 22 | Pages | 10610-10625 |
| PubMed ID | 31785145 | Mgi Jnum | J:296478 |
| Mgi Id | MGI:6467851 | Doi | 10.18632/aging.102480 |
| Citation | Ma X, et al. (2019) Ets2 suppresses inflammatory cytokines through MAPK/NF-kappaB signaling and directly binds to the IL-6 promoter in macrophages. Aging (Albany NY) 11(22):10610-10625 |
| abstractText | Proper activation of Toll-like receptor (TLR)-mediated signaling and production of proinflammatory cytokines are critical for the initiation of innate immunity, while the specific mechanism maintaining inflammatory homeostasis remains mostly unknown. Here, we show that Ets2 is upregulated following LPS and VSV stimulation. Ets2 knockdown or knockout leads to increased IL-6, TNF-alpha, and IFN-beta production in macrophages. Consistently, Ets2-deficient mice show exacerbated inflammatory cytokine production and are more susceptible to CLP-induced sepsis. Mechanistically, Ets2 inhibits the LPS- and VSV-induced activation of ERK1/2, JNK, p38, and p65. Ets2 also binds to the promoter of IL-6 to inhibit transcription. Collectively, the results of the present study show the negative regulatory role of Ets2 in LPS- and VSV-induced inflammation through the suppression of MAPK/NF-kappaB signaling, direct binding to the IL-6 promoter and inhibition of transcription. |
